PMID: 9420807Jul 1, 1995Paper

Mechanism of uptake of technetium-tetrofosmin. II: Uptake into isolated adult rat heart mitochondria

Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
A YounèsA Veyre

Abstract

99mTc-labeled tetrofosmin is a new myocardial imaging agent that gives stable heart uptake. However, little is known about the mechanism of uptake in heart tissue. The aim of this study was to assess the factors responsible for the uptake and retention of 99mTc-labeled tetrofosmin in isolated heart mitochondria. Mitochondria were isolated from adult rat heart tissue with competent metabolic function (i.e., respiratory control ratio of 3 and adenosine diphosphate/oxygen ratio of 2) for succinate oxidation. Intramitochondrial volume measured by the distribution of 3H-water and 14C-sucrose was 1.16 +/- 0.23 microliters/mg protein (mean +/- SD). In the isolated mitochondria, uptake could be demonstrated within 30 seconds of addition of oxidative substrate, but adenosine triphosphate alone did not stimulate marked uptake. Uptake was proportional to the amount of mitochondrial protein over a range of 0.2 to 3 mg protein but independent of Tc-labeled tetrofosmin concentration over a range of 0.4 to 200 pmol/L (0.1 to 50 microCi/ml). The presence of Tc-labeled tetrofosmin had no effect on the oxidative capability of the mitochondria. Use of the mitochondrial uncoupler 2,4-dinitrophenol caused release of 92% of radioactivity. Addition o...Continue Reading

References

Jan 1, 1984·International Journal of Nuclear Medicine and Biology·A G JonesA I Kassis
Jan 1, 1993·European Journal of Nuclear Medicine·P CraneC Orlandi
Jul 1, 1995·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·E A PlattsJ D Kelly

❮ Previous
Next ❯

Citations

Jul 1, 1997·European Journal of Nuclear Medicine·E BombardieriM Greco
Jun 16, 2004·Annals of Nuclear Medicine·Mitsutaka Fukumoto
Mar 18, 2005·Annals of Nuclear Medicine·Gülgün BüyükdereliMustafa Kibar
Aug 2, 2000·Annals of Nuclear Medicine·G Tsujimoto
May 1, 1996·Annals of Nuclear Medicine·A S ArbabT Araki
Aug 22, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Ming YuSimon P Robinson
Mar 17, 2009·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Young-Seung KimShuang Liu
Dec 17, 2009·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Assuero GiorgettiPaolo Marzullo
Jan 31, 2004·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·George A Beller, Steven R Bergmann
Oct 9, 2004·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Yoshiteru AbeHitoshi Tanio
Mar 16, 2001·The American Journal of Cardiology·S MorishitaY Nakaya
Mar 12, 2003·Journal of the American College of Cardiology·Yoshiteru AbeHitoshi Tanio
Mar 1, 1997·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·G A Beller
Jun 29, 1999·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·E NicolaiM Salvatore
Mar 22, 2005·Cancer Biotherapy & Radiopharmaceuticals·Bruno FattoriGiuliano Mariani
Sep 16, 2011·Circulation. Cardiovascular Imaging·Alexis BroisatDavid K Glover
Jun 20, 2014·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Sachiko TakamineKen-ichi Hirata
Jan 11, 2007·Nuclear Medicine and Biology·Henry F VanBrocklinJames P O'Neil
Aug 24, 2011·Contrast Media & Molecular Imaging·Lode R GoethalsTony Lahoutte
Jul 5, 2002·Clinical Radiology·D GopalanP J Ell
Apr 16, 1998·The British Journal of Radiology·C M Medley, G C Vivian
Sep 1, 1996·Acta Radiologica·M IshibashiN Hayabuchi
Nov 10, 2017·Current Treatment Options in Cardiovascular Medicine·Brian M Salata, Parmanand Singh
May 28, 2014·Journal of Labelled Compounds & Radiopharmaceuticals·Bruno L OliveiraJoão D G Correia
Dec 21, 2006·Clinical Nuclear Medicine·Shanthi KannanMatthew Griffiths
Aug 8, 2007·Journal of Veterinary Science·Min Young LeeHo Jae Han
Jul 2, 2010·Organic & Biomolecular Chemistry·Vanesa Fernández-MoreiraMichael P Coogan
Mar 16, 2000·Nuclear Medicine Communications·M SpadaforaP Miletto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.